Candida albicans and Candida dubliniensis are two closely related yeast species associated with human commensalism and opportunistic infection (16) . The echinocandin antifungal class is represented by three agents, anidulafungin (17) , caspofungin (9) , and micafungin (3) . They are cyclic lipopeptides that inhibit ␤-1:3-D-glucan synthesis in fungal cell walls (11) .
Susceptibility tests with echinocandins against yeasts can be done by using the Clinical and Laboratory Standards Institute (CLSI) M27-A method, read visually at 24 h (4), or by the European Committee on Antimicrobial Susceptibility Testing (EUCAST) method, which utilizes a 100-fold-higher initial yeast concentration, a higher (2%) glucose concentration, and spectrophotometric readings to determine 50% endpoints (5) . A "paradoxical effect" has been reported for some C. albicans isolates, in which fungal growth recurs at caspofungin concentrations above the MIC (14, 15) . Trailing yeast growth has been noted in tests of triazole antifungal agents against some yeast isolates but does not indicate resistance of clinical relevance (1, 13) . We recently noticed both phenomena in our routine susceptibility tests with echinocandins and C. dubliniensis isolates and have therefore studied them further.
A panel of 20 C. dubliniensis isolates was selected at random, and a panel of 20 C. albicans isolates was chosen to include genome-sequenced strain SC5314, 10 randomly selected recent clinical isolates, Y109, a reduced-susceptibility clinical isolate (12) , and 8 laboratory mutants of strain SC5314 with reduced echinocandin susceptibility (6, 7) . Anidulafungin, caspofungin, and micafungin pure substances were donated, respectively, by Pfizer United Kingdom, Merck & Co., Inc., and Fujisawa GmBH, and were prepared as a series of aqueous doubling dilutions. Inocula for the M27-A and EUCAST tests were grown overnight at 30°C in neopeptone-yeast extract-glucose (NGY) medium (8) and added to morpholinepropanesulfonic acid (MOPS)-buffered RPMI 1640 medium (10) for M27-A tests or to the same medium with 2% glucose for EUCAST tests, with initial concentrations of 10 3 yeasts/ml and 10 5 yeasts/ ml, respectively. Plates were incubated at 35°C for 24 h. M27-A test MICs were read visually as the lowest concentration at which a marked decrease in visible growth occurred (4), and paradoxical or trailing growth was noted. EUCAST method MICs were read from triplicate spectrophotometric dose-response data as 50% and 80% growth reduction endpoints. Trailing growth was defined as a difference greater than 100-fold between the two endpoints and paradoxical effects as an increase in growth of 5% or more above the dose-response minimum level. Figure 1 illustrates the application of these definitions.
MIC test results for the C. albicans and C. dubliniensis isolate panels are shown in Table 1 . Anidulafungin and caspofungin MIC results for quality control (QC) strains ATCC 6258 and ATCC 22019 fell within published limits for the M27-A tests (4). For EUCAST tests, the caspofungin dose-response curve for ATCC 22019 showed a paradoxical effect, and the 50% endpoint result for ATCC 4258 was one dilution higher than that for the M27-A test QC range (no official EUCAST QC ranges have been published).
For 24-h M27-A tests with C. albicans isolates, the control growth was too low for MIC readings with one isolate (Table FIG. 1). For 19 isolates, MICs of all three echinocandins indicated susceptibility to the agents, except for generally higher MICs with the clinical isolate Y109 and the laboratory-derived echinocandin-resistant mutants (6, 7) . Similarly, among the 20 C. dubliniensis isolates tested by the M27-A method, 2 isolates gave insufficient control growth for determining a MIC, and the remaining 18 isolates were identically susceptible to all three echinocandins (Table 1) . No examples of paradoxical growth or trailing growth were noted in these tests, as judged visually.
With EUCAST tests (Table 1) , all 20 C. albicans isolates gave 24-h echinocandin MIC endpoints that were within one dilution of those determined by the M27-A test, except for caspofungin versus NCPF6525 and B06-341. A paradoxical effect was seen for one isolate tested with anidulafungin and for 10 of the 20 isolates tested with caspofungin. The EUCAST echinocandin 24-h test MICs for micafungin against the C. dubliniensis isolates were within one test dilution of those of M27-A test data. For four C. dubliniensis isolates, anidulafungin and caspofungin MICs were considerably higher with the EUCAST method than with the M27-A method. Paradoxical effects or trailing growth or both phenomena were commonly encountered with all three echinocandins ( Table 1) .
Since these results suggested that the paradoxical effects might be related to the larger inoculum size or higher glucose concentration in EUCAST tests, five C. dubliniensis isolates were retested for caspofungin susceptibility, using RPMI 1640 medium containing 0.2% and 2% glucose and initial concentrations of 10 3 yeasts/ml (M27-A), 10 4 yeasts/ml, and 10 5 yeasts/ml (EUCAST). Read both visually and by spectropho- (2, 12) . C. dubliniensis commonly showed trailing growth and/or paradoxical regrowth at high concentrations of all three echinocandins, whereas for C. albicans isolates, only paradoxical effects were seen. Under M27-A test conditions, the MIC endpoints for each echinocandin were more consistent and trailing growth and paradoxical regrowth were not encountered. However, 3 of the 42 isolates tested grew insufficiently under these conditions to allow MIC determination. Both methods offer 24-h echinocandin MICs. From our data, the M27-A test has the advantage of minimizing paradoxical and trailing growth effects with C. dubliniensis, while the larger inoculum size and higher glucose concentration with the EUCAST approach ensure adequate levels of control growth and generate portable data from spectrophotometric dose-response curves.
With both methodologies, 50% endpoints read at 24 h were similar for the majority of isolates of both yeast species if the paradoxical and trailing growth effects were ignored, suggesting that the effects are artifactual and unlikely to be of clinical relevance.
